-
Ovarian tissue allografts: the next frontier of reproductive transplantation? Fertil. Steril. (IF 6.6) Pub Date : 2024-11-15 Kathryn Coyne,Isabelle Mason,Rebecca Flyckt
-
Classification of Human Ovarian Follicle Morphology: Recommendations of the NICHD-Sponsored Ovarian Nomenclature Workshop. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Jacqueline C Yano Maher,Mary B Zelinski,Kutluk H Oktay,Francesca E Duncan,James H Segars,Marla E Lujan,Hong Lou,Bohyun Yun,Sarina N Hanfling,Lauren E Schwartz,Monica M Laronda,Lisa M Halvorson,Kathleen E O'Neill,Veronica Gomez-Lobo
OBJECTIVE To develop a consensus on histologic human ovarian follicle staging nomenclature, provide guidelines for follicle density calculation, and assess changes due to fixation to enhance communication among clinicians and ovarian biology researchers in order to gain a deeper understanding of human fertility. METHODS Beginning in March 2021, the Ovarian Nomenclature Workshop's Follicle Classification
-
A Long Road Ahead: Medical Management for Endometriosis-Related Pain. Just keep looking. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Jose Carugno,Amira Quevedo,Nash S Moawad
-
Comment on: Endometriosis and mental health disorders: identification and treatment as part of a multimodal approach. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Maria I Zervou,George N Goulielmos
-
An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Srdjan Saso Ph.D., Jen F. Barcroft M.R.C.O.G., Lorraine S. Kasaven M.R.C.O.G., Nicolas Galazis M.R.C.O.G., Bríd Ní Dhonnabháin M.Sc., Karen J. Grewal M.R.C.O.G., Timothy Bracewell-Milnes M.R.C.O.G., Benjamin P. Jones M.R.C.O.G., Natalie Getreu Ph.D., Maxine Chan M.R.C.O.G., Anita Mitra Ph.D., Maya Al-Memar Ph.D., Jara Ben-Nagi M.D., J. Richard Smith Ph.D., Joseph Yazbek M.D., Dirk Timmerman Ph.D.,
Understanding the potential risks associated with fertility treatments (FTs) can guide clinical decision and patient counseling.
-
Triggering oocyte maturation in IVF treatment in normal responders: a systematic review and network meta-analysis. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-13 Yusuf Beebeejaun,Timothy Copeland,James M N Duffy,Ippokratis Sarris,Marian Showell,Rui Wang,Sesh K Sunkara
OBJECTIVE To compare efficacy and safety of hCG, GnRH agonist, dual, and double triggers in predicted normal responders undergoing ovarian stimulation and IVF DESIGN: A systematic review and network meta-analysis of randomized controlled trials (RCTs). DATA SOURCES RCTs indexed in PubMed, MEDLINE, EMBASE, clinical trial registries and Cochrane Database of Systematic Reviews up to December 2023. STUDY
-
Parental Balanced Translocation Carriers do not have Decreased Usable Blastulation Rates or Live Birth Rates Compared to Infertile Controls. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-12 Kyle Nguyen Le,Marcy Maguire,Nicolás Garrido Puchalt,Laura Lidon,Alejandro Sánchez-Martínez,Jason Franasiak,Emily Osman
OBJECTIVE To determine if translocation carriers have a reduced number of usable blastocysts compared to infertile controls. DESIGN Retrospective cohort study. SUBJECTS All cycles of balanced translocation carriers undergoing IVF with preimplantation genetic testing (PGT-SR) for structural rearrangements at a single infertility center compared to an age-matched control cycles of infertile patients
-
-
Why frozen embryo transfer results are lower with vaginal progesterone? Did we miss something? Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Dominique de Ziegler,Sean Soktean,Paul Pirtea
-
Conceiving A New Idea: Fertile Grounds for Large-Scale IVF Mergers. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 A Ferraro,M B Evans
-
Luteinizing Hormone (LH)'s critical role in ovarian stimulation (OS). Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 James P Toner,Paul Pirtea
-
Embryofetoscopy followed by hysteroscopic evacuation of a first-trimester missed abortion in a woman with septate uterus. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 De Angelis Maria Chiara,Borrelli Danilo,Zizolfi Brunella,Gallo Alessandra,Di Spiezio Sardo Attilio,Carugno Jose
-
Childhood adversity and risk of endometriosis, fibroids, and polycystic ovary syndrome: A systematic review. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Sara L Berndt,Leticia Watanabe Ribeiro,Ingrid Rowlands,Jenny Doust,Gita D Mishra
IMPORTANCE While childhood adversity has been extensively studied in relation to various health outcomes, investigation of its association with gynecological conditions remains limited. OBJECTIVE To systematically review studies examining the effect of childhood adversity on the prevalence of three gynecological conditions: endometriosis, fibroids, and polycystic ovary syndrome (PCOS) in the population
-
Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Yutaka Osuga,Takao Kobayashi,Akihiro Hirakawa,Toshiaki Takayanagi,Masayoshi Nogami,Kyaw Tayzar,Takayuki Mochiyama,Masashi Hirayama,Jean-Michel Foidart,Tasuku Harada
OBJECTIVE To evaluate the efficacy and safety of the estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen in Japanese women with primary and secondary dysmenorrhea. DESIGN A 16-week, multi-center, randomized, double-blind, placebo-controlled, parallel-group study, followed by a 36-week, open-label, extension study. SUBJECTS 162 Japanese women with primary and secondary dysmenorrhea
-
Early embryo ontogeny and parental genetic legacy: from developmental mechanisms to diagnosis and treatment. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Giovanni Coticchio,Danilo Cimadomo,Antonio Capalbo,Laura Rienzi
-
Characteristics and outcomes in endometrioma infections: a cohort of 94 cases. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Guillaume Parpex,Martin Belan,Asmaa Tazi,Laetitia Campin,Simon Ganancia,Etienne Canouï,Mathilde Bourdon,Charles Chapron,Louis Marcellin,Caroline Charlier
-
Preeclampsia: More Than Just a Maternal Disease. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Robert T Rydze,Stephanie J Gunderson,Jay Sandlow
-
Freezing Futures: Informed Decision-Making in Elective Oocyte Cryopreservation. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Tamar Schiff,Arthur Caplan,Gwendolyn P Quinn
-
Stepwise approach of hysteroscopic cytoreductive surgery for adenomyosis in patients with recurrent implantation failure. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-06 Rudi Campo,Evy Gillet,Stephan Gordts,Marion Valkenburg,Helena Van Kerrebroeck,Alessa Sugihara,Istvan Argay,Panayiotis Tanos
-
The Effects of BRCA1 and 2 Mutations on Ovarian Reserve and Aging. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-06 Karine Matevossian,May-Tal Sauerbrun-Cutler,Sanjana Konda,Angela Chen,Alexa Steckler,Joyce Ou,Julia N McAdams,Ekaterina Snegovskikh,Robin Cram,Jadis T Chen,Mallory Go,Ashley Stuckey,Kathryn J Grive
-
Human embryos with segmental aneuploidies display delayed early development: a multi-centre morphokinetic analysis. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-05 Matteo Figliuzzi,Lorena Bori,Christian Simon Ottolini,Ludovica Picchetta,Silvia Caroselli,Marco Reverenna,Maurizio Poli,Alison Campbell,Rachel Smith,Giovanni Coticchio,Danilo Cimadomo,Laura Francesca Rienzi,Marcos Meseguer,Antonio Capalbo
OBJECTIVES To assess if segmental aneuploid embryos display unique morphokinetic patterns DESIGN: Retrospective multicentre study including a total of 7,027 embryos cultured between 2016 and 2021 in 3 European IVF centres. Analysis was performed on aggregated multicentre data and separately for data from each centre. Embryos with no more than 4 chromosomal alterations were considered in the analysis
-
Pharmacological and Surgical Strategies to Improve Cryopreserved Ovarian Tissue Transplantation Longevity and Outcomes. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-05 Murat Erden,Kutluk H Oktay
-
Chromosomal abnormalities in oocyte donor candidates: a French survey of over 8200 karyotypes. Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Vincent Puy,Badria Bennani Smires,Jean-Pierre Siffroi,Julie Barberet,Marion Bendayan,Oxana Blagosklonov,Florence Brugnon,Rosalie Cabry-Goubet,Marie-Ange Clarotti,Sophie Catteau-Jonard,Céline Chalas,Lucie Chansel-Debordeaux,Béatrice Delepine,Laetitia Hesters,Stéphanie Lattès,Floriane Lefeuve,Arthur Luton,Catherine Metzler-Guillemain,Sophie Mirallié,Joffrey Mons,Valerica-Gabriela Oancea,Nathalie Rives
OBJECTIVE To study karyotypes of more than 8,200 oocyte donor candidates in nulliparous or multiparous women compared to a reference population. DESIGN A retrospective observational multicentric study. SUBJECTS The study included two cohorts of oocyte donor candidates recruited between January 2005 and October 2021: multiparous women with at least one child at the time of recruitment, and nulliparous
-
Determinants of utilization of infertility services by race and ethnicity in a state with a comprehensive infertility mandate. Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Ann Korkidakis,Veronica Wang,Riwa Sabbagh,Quetrell Heyward,Michele R Hacker,Kim L Thornton,Alan S Penzias
OBJECTIVE To examine the association between sociodemographic factors and utilization of infertility services by race and ethnicity in a state with a comprehensive infertility mandate. DESIGN Retrospective cohort. SETTING Academic-affiliated fertility center. SUBJECTS Women presenting for initial infertility evaluation from January 2010-December 2021. EXPOSURE Initial infertility evaluation and treatment
-
The role of Letrozole in IVF treatment: new remedy or old mirage? Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Nathalie Bülow,Nick Macklon
Aromatase inhibitors, particularly letrozole, are now established as first-line ovulation induction agents, offering an effective ovarian stimulation strategy to enhance outcomes of intrauterine insemination. In recent years, they have also emerged as potentially valuable adjuvants to gonadotropin ovarian stimulation for IVF, particularly in fertility preservation in women with estrogen-responsive
-
Author reply regarding: Maternal stress in pregnancy and pubertal timing in girls and boys: a cohort study. Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Anne Gaml-Sørensen,Nis Brix,Tine Brink Henriksen,Cecilia Høst Ramlau-Hansen
-
Should We Rescue Clubbed Fallopian Tubes? Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Madeline G Kroeger,Jessica D Kresowik
-
Exploring new frontiers in the management of PCOS associated obesity. Fertil. Steril. (IF 6.6) Pub Date : 2024-10-26 Anuja Dokras,Robert Norman
-
Expression of concern: “The effectiveness of clomiphene citrate in LH surge suppression in women undergoing IUI: a randomized controlled trial” (Fertil Steril 2010;94:2167–71) Fertil. Steril. (IF 6.6) Pub Date : 2024-10-24 Hesham Al-Inany M.D. Ph.D., Hamdy Azab M.D., Waleed El-Khayat M.D., Adel Nada M.D., Eman El-Khattan M.D., Ahmed M. Abou-Setta M.D. Ph.D.
-
Reply of the authors: a call for metabolic stratification within obesity research and an urgent need for human, reproductive translational research with glucagon-like peptide 1 receptor agonists Fertil. Steril. (IF 6.6) Pub Date : 2024-10-24 Christina E. Boots M.D. M.S.C.I., Alyse S. Goldberg M.D.
-
-
DELAYED IMPLANTATION IS EXTREMELY UNCOMMON IN FET CYCLES Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Fady I. Sharara B.S. M.D., Anna Lysenko-Brockman MS, Haneen Taha MS.
-
COMPARISON OF PERINATAL OUTCOMES BETWEEN PROGESTIN PRIME OVARIAN STIMULATION (PPOS) PROTOCOL AND GNRH ANTAGONIST PROTOCOL: THE IMPACT OF PPOS ON BIRTH GENDER Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Nanako Iwami M.D., Takeru Fujii M.D., Kanako Takimoto M.D., Miho Kawamata M.D., Naoko Ozawa M.D. Ph.D., Takahiro Yamamoto M.D., Eri Watanabe M.D., Masahito Mizuuchi M.D. PH.D., Osamu Moriwaka M.D., Hirobumi Kamiya M.D. Ph.D.
-
CANNABIS CONSUMPTION REDUCES THE NUMBER OF EUPLOID EMBRYOS AVAILABLE FOR TRANSFER: A RETROSPECTIVE STUDY Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Cyntia Duval PhD, Brandon Wyse B.SC. M.SC., Noga Fuchs Weizman MD, Svetlana Madjunkova M.D. M.SC. P.H.D., Iryna Kuznyetsova PhD, Andree Gauthier Fisher PH.D., Clifford Librach MD
-
-
Author and Spouse/Partner Disclosures Index: Video Sessions Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22
-
Author and Spouse/Partner Disclosures Index: Oral and Poster Sessions Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22
-
-
-
-
EFFECT OF A NEW FERTILIZATION MEDIUM CONTAINING OPTIMIZED AMINO ACID COMPONENTS DERIVED FROM HUMAN OVIDUCT FLUID ON THE FERTILIZATION RATE AND EMBRYO QUALITY AFTER CONVENTIONAL IVF Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Yoshihisa Harada Ph.D., Emi Fukunaga M.Sc., Tomoyo Maeda M.S., Hiyori Sasagawa M.Sc, Maki Ikeda M.D. Ph.D., Reiko Shiba M.D., Shinichiro Okano M.D., Masayuki Kinutani M.D. PH.D.
-
COMPARISON OF FEATURES BETWEEN FRESH AND AUTOLOGOUS VITRIFIED OOCYTES AFTER SIMULTANEOUS FERTILIZATION: CULTURE PARAMETERS AND EMBRYO DEVELOPMENT MORPHOKINETICS RELATED TO AGE Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Clara Gonzalez-Trigo MSc, Julia Cura Ruiz MSc, Beatriz Gonzalez Marti MSc., Julia Jaldo-Garcia MSc., Frida Entezami MD
-
PGT POST-DOBBS: REI PHYSICIAN PERCEPTIONS OF IMPACT ON COUNSELING AND PATIENT DECISION MAKING Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Lizzy Manguso BS BA, Jessica Kline BA, Kellen Mermin-Bunnell BS, Ariana M. Traub MPH, Jennifer F. Kawwass MD, Audrey M. Marsidi M.D.
-
EMBRYO DONATION (ED) MOTIVATIONS, BARRIERS, AND INTERESTS AMONG INDIVIDUALS STORING SURPLUS EMBRYOS Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Deb Roberts MBA, Kelly A. Walker R.N.
-
ASSISTED REPRODUCTIVE TECHNOLOGY USE AND OTHER BASELINE CHARACTERISTICS IMPACT THE ACCEPTABILITY OF TREATMENT FOR PREGNANCY OF UNKNOWN LOCATION: SECONDARY ANALYSIS OF THE ACTORNOT TRIAL Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Archana Ayyar MD, Jacqueline Kloos MD, Fangbai Sun MPH, Heping Zhang PhD, Rachel Susan Weinerman M.D., Kurt T. Barnhart M.D. M.S.C.E.
-
EVALUATION OF MEAN CHANGES IN WEIGHT DURING AND AFTER OVARIAN STIMULATION Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Simone Elder MD, Kerry S.J. Flannagan PhD, Laura X. Zalles M.D., Phillip A. Romanski M.D. M.SC., Cassandra Roeca M.D.
-
PROGESTIN OVULATION SUPPRESSION COMPARED TO OTHER STIMULATION PROTOCOLS IN THE SAME PATIENT: THE GRASS IS NOT ALWAYS GREENER Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Sara C. Pierpoint MD, Scott H. Purcell PH.D., Christopher D. Williams M.D., Laura P. Smith M.D., Linnea R. Goodman M.D.
-
IMPACT OF FAMILY PLANNING DECISIONS AMONG WOMEN IN THE U.S. MILITARY Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Ariel J. Dunn MD, Allison A. Eubanks MD, David Boedeker D.O. MHA, Michael Zamani MS, Trimble Spitzer M.D., Saioa Torrealday MD
-
MANAGEMENT OF AN ATYPICAL ROBERT’S UTERUS VIA SYNCHRONIZED HYSTEROSCOPY AND LAPAROSCOPY Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Jasmine Eliwa M.D., Evelina Manvelyan MD, Emily Marra MD, Kathryn D. Coyne M.D., Joseph Findley M.D., Steven R. Lindheim M.D., Rebecca Flyckt M.D.
-
VARIATIONS IN HYSTEROSCOPIC APPEARANCE OF PARTIAL SEPTATE UTERI AND ARCUATE UTERI Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Sydney Daviskiba MD, Mostafa I. Abuzeid MD
-
AUTOMATED SPERM EVALUATION IN TESTICULAR TISSUE FOR AZOOSPERMIA Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Haocong Song B.E, Wenyuan Chen M.S, Shanshan Wang M.S., Miao Hao M.S., Guanqiao Shan Ph.D., Changsheng Dai Ph.D., Hang Liu PhD, Aojun Jiang M.S., Haixiang Sun M.D. Ph.D., Yu Sun PhD
-
CLINICAL PROCEDURES FOR IN VITRO MATURATION (IVM) TREATMENT Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Michel De Vos M.D. PH.D., Ingrid Segers PhD, Ye Yuan PH.D., Christian Clark Kramme PhD, Robert B. Gilchrist Ph.D.
-
PLOIDY ANOMALIES REVEALED BY ANALYSIS OF CHROMOSOME DYNAMICS FROM 3PN EMBRYOS CONTAINING SMALL PRONUCLEI Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Saki Hashimoto B.S., Yuta Kida M.S., Mikiko Tokoro Ph.D., Noritaka Fukunaga Ph.D., Yoshimasa Asada M.D. Ph.D.
-
SEEING THE INVISIBLE: SUBCELLULAR MORPHOLOGY MEASUREMENT OF LIVE SPERM THROUGH AI-BASED VIRTUAL STAINING Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Wenyuan Chen M.S, Haocong Song B.E, Zhuoran Zhang PH.D., Changsheng Dai Ph.D., Guanqiao Shan Ph.D., Hang Liu PhD, Aojun Jiang M.S., Shivani Nirmalbhai Dhanani BSc, Shruti Bhaskar Pathak BSc, Clifford Librach MD, Yu Sun PhD
-
FACING UNEXPECTED; OVARIAN CYST TURNS OUT TO BE FIMBRIAE HERNIATED THROUGH THE OVARY Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Golnaz Namazi MD
-
HYSTEROSCOPY FOR EARLY PREGNANCY LOSS: MANAGING EPL WITH A REPRODUCTIVE SURGERY MINDSET Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Kelly Ryan MD, Mary McKenna MD, Kirsten Sasaki M.D., Charles E. Miller MD
-
HYSTEROSCOPY TO ASSIST IN DIAGNOSIS AND TREATMENT OF PREGNANCY OF UNKNOWN LOCATION Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Sara C. Pierpoint MD, Linnea R. Goodman M.D.
-
LAPAROSCOPIC APPROACH TO INTERSTITIAL ECTOPIC PREGNANCY: USING A TOURNIQUET SUTURE AND DILUTED VASOPRESSIN Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Luis Oswaldo De La O Perez PH.D., Carlos Armando Bravo Dr MD
-
LAPAROSCOPIC ULTRASOUND DURING MINIMALLY INVASIVE MYOMECTOMY Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Evelyn Minis MD, Christopher Ke Arkfeld MD, Victoria W. Fitz M.D. M.S., John C. Petrozza MD
-
OVARIAN TISSUE ALLOTRANSPLANTATION BETWEEN GENETICALLY NON-IDENTICAL SIBLINGS WITH HLA INCOMPATIBILITY AND IMMUNOSUPPRESSION Fertil. Steril. (IF 6.6) Pub Date : 2024-10-22 Kathryn D. Coyne M.D., Rebecca Flyckt M.D., Daniel C. Brennan MD, Anibal G. Melo MD, Rowena Delos Delos Santos MD, Sherman Silber M.D.